DaVinci Cafe: Longevity Series #2-The Brain

​About Event

​​​In a world driven by rapid and complex challenges, innovation thrives at the convergence of technologies.

​​By bringing together experts from different domain areas, we unlock new possibilities.

​​Welcome to DaVinci Café, where thinkers, creators, and visionaries connect and collaborate.

​​🗓️ Agenda

​​Date: June 4th

​​Address: 2550 Hanover Street | Palo Alto, CA 94304-1115

​​​5:00 PM: check in & networking
5:30-6:30 PM: Panel discussion + Q&A
6:30-7:00 PM: networking 🍕🍺

​​This event will include light appetizers, wine/beer and non-alcoholic beverages.

​​🎙️ Our speakers

​Moderator

​Dr. Garrett Vygantas: Venture investor, CEO, serial entrepreneur.

​

​Garrett Vygantas, MD, MBA is Founder & Managing Partner of Riverine Ventures, a life science and healthcare dedicated venture capital firm. Trained as a physician and an experienced entrepreneur, Garrett provides strategic direction and valuable clinical and commercial networks as a Board Member or Advisor to Adventris Pharma, AEye Health, ArtiSight, CellFE, Ceria Therapeutics, Corsair Pharma, Eliksa Therapeutics, HealthBridge, Inflammatix, KeifeRx, Mediphage and Pieces Technologies.

​With over 20 years, Garrett’s expertise spans across biopharma, life sciences, healthcare, medtech and digital health investing and operations. Before founding Riverine Ventures, he has invested on behalf of The 4100 Group, OSF Healthcare, Jump Capital and Burrill & Co. As an operator, he served as Founding CEO of TherOptix, NewBridge Pharmaceuticals and Mitre Medical and Chief Business Officer of Corsair Pharma. At NewBridge, he and his team raised over $60M in financing and created $470M in nominal value.

​Panel speakers:

​1.       Dr. Alex Colville: Investor in Longevity

​Dr. Alex Colville is the General Partner and cofounder of age1 alongside Laura Deming. age1 is the continuation of the first longevity-focused VC fund founded in 2011 by Laura (5 IPOs). Alex is an advisor and previously served as founding Chief of Staff of the Amaranth Foundation, a family office dedicated to advancing interventions to extend healthy human lifespan where he led investments into over 20 companies and supported philanthropic initiatives including AFAR and the TIME Initiative. Prior to working for family offices, Alex received a PhD in genetics at Stanford University studying rejuvenation and the biology of aging in Tom Rando's lab. During his PhD he consulted for the business development group at Maze Therapeutics and the scientific team at Rubedo Life Sciences.

​2.       Dr. Christin Glorioso: CEO & Co-founder, NeuroAge Therapeutics | Founder & Executive Director, Longevity Global

​ Dr. Christin Glorioso is a neuroscientist, physician, and serial entrepreneur.  She is co-founder and CEO of NeuroAge Therapeutics and Founder and Executive Director of the non-profit, Longevity Global. Christin completed her postdoctoral training at MIT and holds an MD and PhD in Neuroscience from the University of Pittsburgh School of Medicine. 

​3. Dr. Kazu Okuda

​Kazu Okuda, M.D. is a physician turned neuro‑technology entrepreneur driven to improve mental health care. Previously, he was involved in clinical development, fundraising, and ultimately securing regulatory clearance and national insurance reimbursement for an AI-powered medical device at a Japanese med-tech startup. He then moved to the United States to found Universal Brain in 2022, tackling a fundamental gap in psychiatry: the routine measurement of brain function.Universal Brain’s platform captures well-validated brain function measures, called event-related potentials (ERPs), that reflect core neural processes linked to depression and its treatment. By turning these EEG‑based measures into a scalable, clinic‑ready tool, he aims to make objective brain‑function testing a standard component of mental‑health care to get better outcomes—starting with depression and expanding across psychiatric conditions. 

​4. Allison M. Leopold Tilley Partner at Pillsbury Winthrop Shaw Pittman LLP

​​Allison Leopold Tilley is named one of the top “Women Leaders in Tech Law” by The Recorder for six consecutive years and hailed as the Technology “Dealmaker of the Year” by The Deal. Based in Silicon Valley, Allison advises technology companies, including on their formation, venture capital financings, multibillion-dollar M&As, public offerings, securities transactions, SPAC transactions and board governance.

​About the hosts & sponsors:

​​​​​​​​​​Hosts: Davinci Cafe: Where thinkers, creators, and visionaries from every industry connect, collaborate, and shape the future. Find your tribe, your partners, and your inspiration.

​​​Sponsors: Pillsbury Winthrop Shaw Pittman LLP: ​​A global law firm focusing on the Tech, Energy, Financial, Real Estate & Construction, and Life Sciences industries.

​​​​Please note, this event may be photographed and filmed. Davinci Cafe reserves the right to use photographs and video from the event for marketing and communications purposes. By attending the event you consent to your image being used for these purposes.

To maintain the integrity of our peer collaboration and to respect venue capacity, we will not accommodate walk-ins or +1s for the event. Thank you in advance for your cooperation.